Records Clause Example from Business Contracts

This example Records clause appears in 14 contracts from 7 companies

Records. I agree to keep and maintain adequate and current records (in the form of notes, sketches, drawings and in any other form that is required by Company) of all Confidential Information developed by me and all Company Inventions made by me during the period of my employment at Company, which records will be available to and remain the sole property of Company at all times.
Found in Allogene Therapeutics, Inc. contract
Verrica Pharmaceuticals Inc. Contracts

Amended and Restated Employment Agreement between Verrica Pharmaceuticals Inc. and Patrick Burnett, MD (Filed With SEC on March 13, 2020)

Allogene Therapeutics, Inc. Contracts

Employment Agreement between Allogene Therapeutics, Inc. and Rafael G. Amado, M.D. (Filed With SEC on February 27, 2020)

Allogene Therapeutics, Inc. Employment Agreement with Veer Bhavnagri (General Counsel) (Filed With SEC on May 6, 2020)

Allogene Therapeutics, Inc. Employment Agreement with Zachary Roberts (EVP, Head of R&D) (Filed With SEC on February 28, 2023)

Allogene Therapeutics, Inc. Employment Agreement with David Chang, M.D., Ph.D. (Filed With SEC on September 14, 2018)

Allogene Therapeutics, Inc. Employment Agreement with Eric Schmidt (Chief Financial Officer) (Filed With SEC on September 14, 2018)

Allogene Therapeutics, Inc. Employment Agreement with Alison Moore (Chief Technical Officer) (Filed With SEC on September 14, 2018)

BIOVIE INC. Contracts

BioVie, Inc. Executive Employment Offer Letter to Dr. Joseph M. Palumbo (EVP & Chief Medical Officer) (Filed With SEC on November 10, 2021)

Clearside Biomedical, Inc. Contracts

Clearside Biomedical, Inc. Interim CEO Executive Employment Agreement with George Lasezkay (April 2019) (Filed With SEC on April 17, 2019)

PROTEOSTASIS THERAPEUTICS, INC. Contracts

Amended and Restated Employment Agreement between Proteostasis Therapeutics, Inc. and Executive (Filed With SEC on March 10, 2020)

AN2 Therapeutics, Inc. Contracts

AN2 Therapeutics, Inc. Employment Offer Letter to Eric Easom (President and CEO) (Filed With SEC on March 4, 2022)

AN2 Therapeutics, Inc. Employment Offer Letter to Lucy O. Day (Chief Financial Officer) (Filed With SEC on March 4, 2022)

AN2 Therapeutics, Inc. Employment Offer Letter to Sanjay Chanda, Ph.D. (Chief Development Officer) (Filed With SEC on March 4, 2022)

Synthetic Biologics, Inc. Contracts

Separation Agreement between Synthetic Biologics, Inc. and Jeffrey Riley dated December 5, 2017 (Filed With SEC on December 7, 2017)